11 Oct 2019

Transparency notification BlackRock, Inc.

Read More
10 Oct 2019

UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases

Read More
9 Oct 2019

UCB Showcases Wealth of new Psoriasis Research at EADV 2019

Read More
8 Oct 2019

Transparency notification Wellington

Read More
8 Oct 2019

Transparency notification BlackRock, Inc.

Read More
27 Sep 2019

Transparency notification BlackRock, Inc.

Read More
25 Sep 2019

UCB presents UCB0107 anti-Tau immunotherapy Phase I study results at World Movement Disorders Conference®

Read More
24 Sep 2019

Transparency notifications BlackRock, Inc.

Read More
20 Sep 2019

Experts consider osteoporosis to be a silent epidemic which is neglected and under addressed, according to new survey released today

Read More
19 Sep 2019

Transparency notification BlackRock, Inc.

Read More
Subscribe to